Lys-Lys-IRS-1 (891-902) (dephosphorylated) (human) is a peptide from the insulin receptor substrate 1 containing regulatory tyrosine sites in their unphosphorylated state. The sequence is valuable for studying kinase-substrate recognition and basal conformations. Researchers use it to compare phosphorylated and dephosphorylated forms in signaling assays. Its defined composition supports mechanistic pathway analysis.
CAT No: I01007
CAS No:172615-51-9
Synonyms/Alias:Lys-Lys-Insulin Receptor Substrate-1 (891-902) (dephosphorylated) (human), Lys-Lys-IRS-1 (886-897) (dephosphorylated) (mouse), Lys-Lys-IRS-1 (890-901) (dephosphorylated) (rat), IGF1RK Peptide Substrate
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Emu oil in combination with other active ingredients for treating skin imperfections
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.